Food and Drug Administration
Nonprescription Drugs Advisory Committee
September 20, 2002
Slides
Presentation on OTC Drug Products, Dr. Charles Ganley, MD, FDA htm ppt
Overview of Aspirin and NSAID's Label Warnings, Dr. William Gilbertson, PharmD., FDA htm ppt
OTC NSAID and ASA GI Bleeding Analysis of Spontaneous Reports, Dr. Joyce Weaver, PharmD., FDA htm ppt
Risks of NSAIDS: Focus on GI Risks of OTC NSAIDs, Dr. Byron Cryer, MD, U. of Texas Southwestern Medical School htm ppt
OTC NSAIDs and Nephrotoxicity, Dr. Juan Pelayo, MD, FDA htm ppt
NSAIDs and GI and Renal Complications, Lessons from Tennessee Medicaid Population Studies (and selected others) htm ppt
Epidemiology of Aspirin and Other NSAIDs, Dr. Kenneth Rothman, DrPH, Boston University htm ppt
Presentations by Dr. Roger Berlin, MD, et. al., Global Scientific Affairs Wyeth htm ppt
Presentation on Bayer OTC Analgesic Products, Dr. Allen Heller, MD, Bayer Corp. Consumer Care Division htm ppt
Risk of GI Bleed on NSAIDs, Prof. Michael Langman, U. of Birmingham, UK htm ppt
Ibuprofen and Renal Failure, Prof. Nicholas Moore, U. of Bordeaux, France htm ppt
Open Public Hearing
Acetaminophen Overdoses: A Review of Intentional and Unintentional Cases, Dr. Sarah Erush, PharmD, BCPS and Dr. Karen Shalaby, PharmD, Hospital of the U. of Pennsylvania htm ppt